Correlation Between Virax Biolabs and OncoSec Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and OncoSec Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and OncoSec Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and OncoSec Medical, you can compare the effects of market volatilities on Virax Biolabs and OncoSec Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of OncoSec Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and OncoSec Medical.

Diversification Opportunities for Virax Biolabs and OncoSec Medical

-0.25
  Correlation Coefficient

Very good diversification

The 3 months correlation between Virax and OncoSec is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and OncoSec Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OncoSec Medical and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with OncoSec Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OncoSec Medical has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and OncoSec Medical go up and down completely randomly.

Pair Corralation between Virax Biolabs and OncoSec Medical

If you would invest  192.00  in Virax Biolabs Group on October 22, 2024 and sell it today you would earn a total of  26.00  from holding Virax Biolabs Group or generate 13.54% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy5.26%
ValuesDaily Returns

Virax Biolabs Group  vs.  OncoSec Medical

 Performance 
       Timeline  
Virax Biolabs Group 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Virax Biolabs Group are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Virax Biolabs showed solid returns over the last few months and may actually be approaching a breakup point.
OncoSec Medical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OncoSec Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, OncoSec Medical is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Virax Biolabs and OncoSec Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Virax Biolabs and OncoSec Medical

The main advantage of trading using opposite Virax Biolabs and OncoSec Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, OncoSec Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OncoSec Medical will offset losses from the drop in OncoSec Medical's long position.
The idea behind Virax Biolabs Group and OncoSec Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.